- Luckin Coffee IPO won't stop Starbucks' stock breakout, technical analyst says
- Labour declares Brexit talks dead as May’s premiership crumbles
- Amazon squares up to Uber with backing for UK food app Deliveroo
- Carrefour considers sale of stake in China business: sources
- The Latest: German government still urging Brexit deal
FILE PHOTO – Shoppers walk outside a CVS store and pharmacy in Medford, Massachusetts, U.S. December 4, 2017. REUTERS/Brian Snyder
October 10, 2018
WASHINGTON (Reuters) – Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc, the Justice Department said on Wednesday, paving the way for a combination the companies say can help cut soaring U.S. healthcare costs.
It is the second large recent healthcare deal to win antitrust approval from the U.S. Justice Department. The agency gave the green light to health insurer Cigna Corp’s $52 billion acquisition of the nation’s largest pharmacy benefit manager, Express Scripts Holding Co, on Sept. 17.
(Reporting by Diane Bartz; Editing by Bill Berkrot)